GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Turk Ilac ve Serum Sanayi (IST:TRILC) » Definitions » EV-to-EBITDA

Turk Ilac ve Serumnayi (IST:TRILC) EV-to-EBITDA : 21.24 (As of May. 27, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Turk Ilac ve Serumnayi EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Turk Ilac ve Serumnayi's enterprise value is ₺5,139 Mil. Turk Ilac ve Serumnayi's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was ₺242 Mil. Therefore, Turk Ilac ve Serumnayi's EV-to-EBITDA for today is 21.24.

The historical rank and industry rank for Turk Ilac ve Serumnayi's EV-to-EBITDA or its related term are showing as below:

IST:TRILC' s EV-to-EBITDA Range Over the Past 10 Years
Min: 8.59   Med: 16.07   Max: 53.04
Current: 21.24

During the past 6 years, the highest EV-to-EBITDA of Turk Ilac ve Serumnayi was 53.04. The lowest was 8.59. And the median was 16.07.

IST:TRILC's EV-to-EBITDA is ranked worse than
68.81% of 715 companies
in the Drug Manufacturers industry
Industry Median: 14.57 vs IST:TRILC: 21.24

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-27), Turk Ilac ve Serumnayi's stock price is ₺29.82. Turk Ilac ve Serumnayi's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was ₺0.558. Therefore, Turk Ilac ve Serumnayi's PE Ratio for today is 53.44.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Turk Ilac ve Serumnayi EV-to-EBITDA Historical Data

The historical data trend for Turk Ilac ve Serumnayi's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Turk Ilac ve Serumnayi EV-to-EBITDA Chart

Turk Ilac ve Serumnayi Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-EBITDA
Get a 7-Day Free Trial - - - 23.60 14.06

Turk Ilac ve Serumnayi Quarterly Data
Dec17 Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.89 14.06 9.09 8.62 11.75

Competitive Comparison of Turk Ilac ve Serumnayi's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Turk Ilac ve Serumnayi's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Turk Ilac ve Serumnayi's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Turk Ilac ve Serumnayi's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Turk Ilac ve Serumnayi's EV-to-EBITDA falls into.



Turk Ilac ve Serumnayi EV-to-EBITDA Calculation

Turk Ilac ve Serumnayi's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=5138.925/241.921
=21.24

Turk Ilac ve Serumnayi's current Enterprise Value is ₺5,139 Mil.
Turk Ilac ve Serumnayi's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺242 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Turk Ilac ve Serumnayi  (IST:TRILC) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Turk Ilac ve Serumnayi's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=29.82/0.558
=53.44

Turk Ilac ve Serumnayi's share price for today is ₺29.82.
Turk Ilac ve Serumnayi's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺0.558.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Turk Ilac ve Serumnayi EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Turk Ilac ve Serumnayi's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Turk Ilac ve Serumnayi (IST:TRILC) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Bügduz Mah. Enver Pasa Cad., No: 8 Akyurt, Ankara, TUR, TR 06750
Turk Ilac ve Serum Sanayi is engaged in the production of human pharmaceuticals and vaccines.

Turk Ilac ve Serumnayi (IST:TRILC) Headlines

No Headlines